Free Newsletter
FDA gets meager funding boost
Any big fix at the FDA may have to wait for a new president. The White House's proposed budget includes a funding increase of just 5.7 percent for the agency, a hike that's significantly absorbed by inflation. It's a far cry from the double-or-nothing some experts have said is crucial to bringing the FDA up to speed.
The $2.4 billion budget won't be greeted by cheers from any but the most die-hard anti-government types. Over the past couple of months, report after report has shown that FDA is in dire need of more bucks and more bodies to deal with big leaps forward in science and huge increases in imports of food and drugs.
Of course Congress might boost FDA funding levels, but that boost would have to make it past the president's desk. For his part, Commissioner Andrew von Eschenbach sounded sanguine about the proposal--"This budget enables us to continue development of the staff and programs necessary," he said in a statement--but it is his boss's budget, after all. Other observers weren't so satisfied. Without Congressional intervention, the agency will be stuck "treading water," one expert said.
- see the FDA's release
- read the report from USA Today
- check out the article in the Wall Street Journal
Related Articles:
FDA in crisis? Then show them the money. Report
Agreed in committee: FDA needs money. Report
GAO assails FDA's foreign inspections. Report
FDA wants satellite offices overseas. Report
FDA badly needs more money, staff. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





